Tap to unmute
Heart risk after vaccines
Umieść na stronie
- Opublikowany 24 lis 2021
- Does the risk of a heart attack increase from 11% up to 25%
Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning (8th November)
Measurement of multiple protein biomarkers,
which generates a score predicting the 5 year risk (percentage chance) of a new Acute Coronary Syndrome
Score is based on changes from the norm of multiple protein biomarkers,
IL-16, (a proinflammatory cytokine)
Soluble Fas, (an inducer of apoptosis)
FasL is the ligand
adenoviral overexpression of FasL
Hepatocyte Growth Factor (serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue)
Among other markers
Elevation above the norm increases the PULS score
Decreases below the norm lowers the PULS score
The score has been measured every 3-6 months in our patient population for 8 years.
Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer,
dramatic changes in the PULS score became apparent in most patients.
This report summarizes those results
A total of 566 patients,
aged 28 to 97,
M:F ratio 1:1
seen in a preventive cardiology practice
had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot
and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot.
Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac;
sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac;
HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac.
These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk.
At the time of this report, these changes persist for at least 2.5 months post second dose of vac.
We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle
and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.
Dr. Stephen R Gundry
Our group has been using the PLUS Cardiac Test
The Joint Committee on Vaccination and Immunisation (JCVI) advises UK health departments on immunisation